| Trial ID: | L1204 |
| Source ID: | NCT01391520
|
| Associated Drug: |
Deferiprone
|
| Title: |
Efficacy and Safety of Deferiprone in Patients With Chronic Kidney Disease Undergoing a Cardiac Catheterization and Receiving Contrast Agent
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Kidney Injury
|
| Interventions: |
DRUG: deferiprone|DRUG: Placebo
|
| Outcome Measures: |
Primary: A composite of renal and cardiovascular clinical events occurring through Day 90, Day 90 following index cardiac catheterization |
|
| Sponsor/Collaborators: |
Sponsor: CorMedix
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2012-01
|
| Completion Date: |
2013-06
|
| Results First Posted: |
|
| Last Update Posted: |
2020-08-24
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01391520
|
